Mandy Brown Belfort, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Milk, Human | 39 | 2023 | 490 | 12.800 |
Why?
|
Infant, Premature | 44 | 2023 | 2039 | 8.850 |
Why?
|
Breast Feeding | 21 | 2023 | 1334 | 4.180 |
Why?
|
Child Development | 20 | 2023 | 2213 | 4.070 |
Why?
|
Infant Formula | 9 | 2022 | 200 | 3.280 |
Why?
|
Infant Nutritional Physiological Phenomena | 13 | 2023 | 344 | 3.000 |
Why?
|
Infant, Very Low Birth Weight | 17 | 2022 | 407 | 2.970 |
Why?
|
Intensive Care Units, Neonatal | 22 | 2023 | 773 | 2.820 |
Why?
|
Milk Banks | 7 | 2020 | 15 | 2.650 |
Why?
|
Infant, Newborn | 85 | 2023 | 25470 | 2.510 |
Why?
|
Weight Gain | 20 | 2021 | 2278 | 2.400 |
Why?
|
Body Composition | 9 | 2022 | 2397 | 2.130 |
Why?
|
Premature Birth | 11 | 2023 | 1702 | 1.960 |
Why?
|
Gestational Age | 25 | 2023 | 3486 | 1.710 |
Why?
|
Infant, Premature, Diseases | 4 | 2023 | 704 | 1.530 |
Why?
|
Infant | 64 | 2023 | 34923 | 1.510 |
Why?
|
Fetal Development | 6 | 2022 | 763 | 1.480 |
Why?
|
Birth Weight | 13 | 2023 | 2062 | 1.450 |
Why?
|
Infant, Low Birth Weight | 7 | 2021 | 848 | 1.280 |
Why?
|
Body Weight | 13 | 2021 | 4660 | 1.140 |
Why?
|
Infant, Newborn, Diseases | 2 | 2021 | 578 | 1.030 |
Why?
|
Eating | 2 | 2021 | 1526 | 0.940 |
Why?
|
Parents | 4 | 2019 | 3368 | 0.920 |
Why?
|
Blood Pressure | 12 | 2019 | 8554 | 0.900 |
Why?
|
Adiposity | 6 | 2022 | 1801 | 0.900 |
Why?
|
Growth Charts | 2 | 2020 | 61 | 0.880 |
Why?
|
Brain | 11 | 2023 | 26345 | 0.840 |
Why?
|
Developmental Disabilities | 3 | 2015 | 1445 | 0.790 |
Why?
|
Spinal Dysraphism | 1 | 2023 | 154 | 0.780 |
Why?
|
Body Size | 3 | 2019 | 458 | 0.780 |
Why?
|
Intelligence | 4 | 2018 | 919 | 0.780 |
Why?
|
Diet | 9 | 2020 | 7876 | 0.780 |
Why?
|
Maternal Nutritional Physiological Phenomena | 3 | 2019 | 378 | 0.740 |
Why?
|
Fetus | 5 | 2022 | 1877 | 0.710 |
Why?
|
Umbilical Arteries | 3 | 2016 | 75 | 0.670 |
Why?
|
Pregnancy | 34 | 2023 | 29002 | 0.670 |
Why?
|
Cognition | 8 | 2023 | 6686 | 0.660 |
Why?
|
Patient Discharge | 8 | 2022 | 3286 | 0.660 |
Why?
|
Food, Fortified | 4 | 2023 | 187 | 0.650 |
Why?
|
Electronic Mail | 2 | 2017 | 214 | 0.650 |
Why?
|
Body Mass Index | 18 | 2023 | 12655 | 0.630 |
Why?
|
Nutritional Status | 4 | 2022 | 1587 | 0.630 |
Why?
|
Hospitals, Maternity | 1 | 2017 | 42 | 0.610 |
Why?
|
Prenatal Care | 2 | 2017 | 1087 | 0.600 |
Why?
|
Hormones | 1 | 2021 | 880 | 0.590 |
Why?
|
Mothers | 5 | 2022 | 2143 | 0.590 |
Why?
|
Child Nutrition Sciences | 1 | 2016 | 23 | 0.570 |
Why?
|
Female | 83 | 2023 | 378853 | 0.570 |
Why?
|
Pregnancy Trimesters | 1 | 2017 | 192 | 0.560 |
Why?
|
Enteral Nutrition | 3 | 2018 | 758 | 0.540 |
Why?
|
Body Height | 7 | 2021 | 1577 | 0.540 |
Why?
|
Humans | 112 | 2023 | 739398 | 0.540 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2021 | 1331 | 0.530 |
Why?
|
Lactation | 6 | 2023 | 410 | 0.500 |
Why?
|
Diffusion Tensor Imaging | 2 | 2022 | 2301 | 0.500 |
Why?
|
Fetofetal Transfusion | 1 | 2016 | 104 | 0.500 |
Why?
|
Massachusetts | 10 | 2022 | 8669 | 0.490 |
Why?
|
Parent-Child Relations | 2 | 2017 | 746 | 0.480 |
Why?
|
Ultrasonography, Doppler | 1 | 2016 | 460 | 0.470 |
Why?
|
Delivery, Obstetric | 1 | 2021 | 914 | 0.460 |
Why?
|
Growth | 2 | 2013 | 377 | 0.460 |
Why?
|
Iodine | 2 | 2014 | 285 | 0.450 |
Why?
|
Pregnancy Trimester, Second | 3 | 2012 | 732 | 0.450 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2021 | 2028 | 0.450 |
Why?
|
Seafood | 2 | 2013 | 379 | 0.440 |
Why?
|
Motor Skills Disorders | 1 | 2012 | 90 | 0.430 |
Why?
|
Parenteral Nutrition Solutions | 1 | 2012 | 27 | 0.420 |
Why?
|
Food, Formulated | 1 | 2012 | 109 | 0.400 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2012 | 232 | 0.400 |
Why?
|
Middle Cerebral Artery | 1 | 2012 | 277 | 0.390 |
Why?
|
Child, Preschool | 21 | 2023 | 40802 | 0.380 |
Why?
|
Vascular Resistance | 2 | 2012 | 943 | 0.370 |
Why?
|
Longitudinal Studies | 9 | 2021 | 13880 | 0.370 |
Why?
|
Male | 49 | 2023 | 349022 | 0.370 |
Why?
|
Executive Function | 2 | 2016 | 1356 | 0.370 |
Why?
|
Perinatal Care | 2 | 2011 | 225 | 0.360 |
Why?
|
Child Behavior | 1 | 2016 | 836 | 0.360 |
Why?
|
Docosahexaenoic Acids | 2 | 2020 | 873 | 0.350 |
Why?
|
Counseling | 1 | 2017 | 1526 | 0.350 |
Why?
|
Cephalometry | 2 | 2021 | 381 | 0.340 |
Why?
|
Parturition | 2 | 2023 | 431 | 0.340 |
Why?
|
Hypertension | 3 | 2015 | 8431 | 0.330 |
Why?
|
Intensive Care, Neonatal | 3 | 2019 | 197 | 0.330 |
Why?
|
Hospitalization | 4 | 2021 | 10208 | 0.320 |
Why?
|
Child | 23 | 2023 | 77033 | 0.310 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2019 | 2393 | 0.300 |
Why?
|
Psychomotor Performance | 2 | 2016 | 1899 | 0.300 |
Why?
|
Body Fluid Compartments | 2 | 2017 | 52 | 0.300 |
Why?
|
Iron, Dietary | 1 | 2008 | 141 | 0.290 |
Why?
|
Patient Compliance | 1 | 2017 | 2679 | 0.290 |
Why?
|
Enterocolitis, Necrotizing | 2 | 2021 | 339 | 0.290 |
Why?
|
Pre-Eclampsia | 2 | 2012 | 1194 | 0.290 |
Why?
|
Leptin | 4 | 2021 | 1589 | 0.280 |
Why?
|
Healthcare Disparities | 2 | 2019 | 3138 | 0.280 |
Why?
|
Australia | 2 | 2022 | 1162 | 0.280 |
Why?
|
Depression, Postpartum | 1 | 2010 | 335 | 0.270 |
Why?
|
Antibodies, Viral | 3 | 2021 | 3151 | 0.270 |
Why?
|
Head | 3 | 2019 | 876 | 0.260 |
Why?
|
Ultrasonography, Prenatal | 4 | 2016 | 1689 | 0.260 |
Why?
|
Health Status Indicators | 1 | 2011 | 969 | 0.260 |
Why?
|
Dietary Supplements | 4 | 2021 | 3279 | 0.250 |
Why?
|
Obesity | 12 | 2022 | 12643 | 0.240 |
Why?
|
Oligosaccharides | 2 | 2023 | 417 | 0.240 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3021 | 0.240 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2021 | 9812 | 0.230 |
Why?
|
Lactose | 1 | 2023 | 95 | 0.230 |
Why?
|
Thinness | 3 | 2017 | 475 | 0.220 |
Why?
|
Inflammation | 2 | 2022 | 10534 | 0.220 |
Why?
|
Adult | 26 | 2022 | 213394 | 0.210 |
Why?
|
Plethysmography | 2 | 2019 | 180 | 0.210 |
Why?
|
Fetoscopy | 1 | 2023 | 121 | 0.210 |
Why?
|
Internet | 1 | 2014 | 3048 | 0.210 |
Why?
|
Prospective Studies | 13 | 2023 | 53037 | 0.200 |
Why?
|
Pregnancy Outcome | 4 | 2021 | 2789 | 0.200 |
Why?
|
Linear Models | 4 | 2023 | 5948 | 0.200 |
Why?
|
Fetal Growth Retardation | 2 | 2023 | 570 | 0.200 |
Why?
|
Fetal Blood | 2 | 2022 | 1315 | 0.190 |
Why?
|
Infant Welfare | 2 | 2013 | 82 | 0.190 |
Why?
|
Exercise | 1 | 2017 | 5591 | 0.190 |
Why?
|
Colorado | 2 | 2017 | 163 | 0.190 |
Why?
|
Memory, Short-Term | 2 | 2018 | 974 | 0.190 |
Why?
|
Boston | 6 | 2018 | 9314 | 0.190 |
Why?
|
Laparotomy | 1 | 2023 | 472 | 0.180 |
Why?
|
Turkey | 1 | 2020 | 234 | 0.180 |
Why?
|
Disease Susceptibility | 1 | 2007 | 1778 | 0.180 |
Why?
|
Motor Skills | 1 | 2023 | 520 | 0.180 |
Why?
|
Vermont | 1 | 2019 | 83 | 0.170 |
Why?
|
Bottle Feeding | 1 | 2019 | 68 | 0.170 |
Why?
|
Fat Emulsions, Intravenous | 2 | 2013 | 321 | 0.170 |
Why?
|
Risk Factors | 13 | 2021 | 71974 | 0.170 |
Why?
|
Vasodilation | 2 | 2012 | 947 | 0.170 |
Why?
|
Time Factors | 10 | 2019 | 40050 | 0.170 |
Why?
|
Crown-Rump Length | 1 | 2018 | 32 | 0.170 |
Why?
|
Cervix Uteri | 1 | 2023 | 591 | 0.170 |
Why?
|
Cohort Studies | 11 | 2022 | 40389 | 0.170 |
Why?
|
Placenta | 2 | 2020 | 1682 | 0.160 |
Why?
|
Logistic Models | 5 | 2017 | 13402 | 0.160 |
Why?
|
Interleukin-8 | 1 | 2021 | 685 | 0.160 |
Why?
|
Carbon Dioxide | 1 | 2023 | 1142 | 0.160 |
Why?
|
Immunoglobulin A | 1 | 2021 | 989 | 0.160 |
Why?
|
Oklahoma | 1 | 2017 | 37 | 0.160 |
Why?
|
Quality of Life | 3 | 2017 | 12640 | 0.160 |
Why?
|
Neonatal Nursing | 1 | 2017 | 22 | 0.160 |
Why?
|
Infant Care | 1 | 2019 | 184 | 0.150 |
Why?
|
Asthma | 2 | 2015 | 5950 | 0.150 |
Why?
|
Systole | 2 | 2011 | 956 | 0.150 |
Why?
|
Infant, Small for Gestational Age | 2 | 2013 | 438 | 0.150 |
Why?
|
Heart Failure | 1 | 2021 | 10793 | 0.150 |
Why?
|
Follow-Up Studies | 8 | 2018 | 38942 | 0.150 |
Why?
|
North Carolina | 1 | 2017 | 310 | 0.150 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2022 | 3636 | 0.140 |
Why?
|
Anthropometry | 2 | 2018 | 1344 | 0.140 |
Why?
|
Aftercare | 1 | 2022 | 858 | 0.140 |
Why?
|
Neck | 1 | 2000 | 691 | 0.140 |
Why?
|
Posture | 1 | 2000 | 966 | 0.140 |
Why?
|
Reference Values | 2 | 2020 | 4983 | 0.130 |
Why?
|
Prevalence | 5 | 2020 | 15153 | 0.130 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 24714 | 0.130 |
Why?
|
Prehypertension | 1 | 2015 | 61 | 0.130 |
Why?
|
Policy Making | 1 | 2019 | 554 | 0.130 |
Why?
|
Adipose Tissue | 2 | 2017 | 3280 | 0.130 |
Why?
|
Adiponectin | 1 | 2021 | 1096 | 0.130 |
Why?
|
Plasma Substitutes | 1 | 1994 | 56 | 0.120 |
Why?
|
New England | 1 | 2017 | 1021 | 0.120 |
Why?
|
United States | 11 | 2022 | 69573 | 0.120 |
Why?
|
Twins, Monozygotic | 1 | 2016 | 457 | 0.120 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7726 | 0.120 |
Why?
|
Absorptiometry, Photon | 2 | 2017 | 1726 | 0.120 |
Why?
|
Energy Intake | 2 | 2020 | 2135 | 0.120 |
Why?
|
India | 1 | 2020 | 2189 | 0.120 |
Why?
|
Verapamil | 1 | 1994 | 244 | 0.120 |
Why?
|
Multivariate Analysis | 6 | 2016 | 12237 | 0.120 |
Why?
|
Quality Improvement | 2 | 2019 | 3730 | 0.120 |
Why?
|
Body Weights and Measures | 1 | 2014 | 209 | 0.120 |
Why?
|
Regression Analysis | 3 | 2020 | 6452 | 0.120 |
Why?
|
Overweight | 3 | 2018 | 2355 | 0.110 |
Why?
|
Apgar Score | 1 | 2012 | 123 | 0.110 |
Why?
|
Blood Volume | 1 | 1994 | 565 | 0.110 |
Why?
|
Soybean Oil | 1 | 2013 | 133 | 0.110 |
Why?
|
Parenteral Nutrition | 2 | 2014 | 649 | 0.110 |
Why?
|
Dextrans | 1 | 1994 | 590 | 0.100 |
Why?
|
Blood Flow Velocity | 2 | 2012 | 1437 | 0.100 |
Why?
|
Guideline Adherence | 3 | 2018 | 2261 | 0.100 |
Why?
|
Thyroid Hormones | 1 | 2014 | 387 | 0.100 |
Why?
|
Interleukin-6 | 1 | 2021 | 3194 | 0.100 |
Why?
|
Hospitals | 2 | 2022 | 3916 | 0.100 |
Why?
|
Obstetrics | 1 | 2018 | 660 | 0.100 |
Why?
|
Psychological Tests | 1 | 2013 | 649 | 0.100 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1957 | 0.100 |
Why?
|
Health | 1 | 2014 | 390 | 0.100 |
Why?
|
Retrospective Studies | 6 | 2023 | 76631 | 0.090 |
Why?
|
Adolescent | 9 | 2022 | 85405 | 0.090 |
Why?
|
Exercise Therapy | 1 | 2017 | 897 | 0.090 |
Why?
|
Nutritional Requirements | 1 | 2012 | 283 | 0.090 |
Why?
|
Cholestasis | 1 | 2013 | 371 | 0.090 |
Why?
|
Data Interpretation, Statistical | 1 | 2020 | 2716 | 0.090 |
Why?
|
Developed Countries | 1 | 2013 | 433 | 0.090 |
Why?
|
Uterus | 1 | 1994 | 712 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2021 | 4400 | 0.090 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3752 | 0.090 |
Why?
|
Cesarean Section | 1 | 2018 | 1371 | 0.090 |
Why?
|
Fish Oils | 1 | 2013 | 469 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 4 | 2023 | 35326 | 0.090 |
Why?
|
Language Development | 1 | 2010 | 187 | 0.090 |
Why?
|
Diet Surveys | 1 | 2013 | 1165 | 0.090 |
Why?
|
Diabetes, Gestational | 3 | 2019 | 1174 | 0.090 |
Why?
|
Pilot Projects | 2 | 2021 | 8275 | 0.080 |
Why?
|
Infant, Extremely Low Birth Weight | 1 | 2009 | 88 | 0.080 |
Why?
|
Nutritive Value | 1 | 2012 | 335 | 0.080 |
Why?
|
Social Behavior | 1 | 2016 | 1131 | 0.080 |
Why?
|
Hospitals, University | 1 | 2011 | 567 | 0.080 |
Why?
|
Maternal Welfare | 1 | 2009 | 115 | 0.080 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2011 | 392 | 0.080 |
Why?
|
Parenteral Nutrition, Total | 1 | 2009 | 300 | 0.080 |
Why?
|
Adrenergic Agonists | 1 | 2008 | 58 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2017 | 5058 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6516 | 0.080 |
Why?
|
Predictive Value of Tests | 3 | 2012 | 15036 | 0.080 |
Why?
|
Young Adult | 6 | 2017 | 56255 | 0.080 |
Why?
|
Sepsis | 1 | 2021 | 2571 | 0.080 |
Why?
|
Erythrocyte Indices | 1 | 2008 | 146 | 0.070 |
Why?
|
Length of Stay | 2 | 2018 | 6295 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2749 | 0.070 |
Why?
|
Risk Assessment | 2 | 2018 | 23294 | 0.070 |
Why?
|
Nutrition Policy | 1 | 2010 | 486 | 0.070 |
Why?
|
Nutrition Assessment | 1 | 2009 | 717 | 0.070 |
Why?
|
Pregnancy Trimester, Third | 1 | 2008 | 568 | 0.070 |
Why?
|
Pandemics | 2 | 2022 | 8274 | 0.060 |
Why?
|
Genomic Imprinting | 1 | 2007 | 331 | 0.060 |
Why?
|
ROC Curve | 1 | 2012 | 3526 | 0.060 |
Why?
|
Respiration Disorders | 1 | 2008 | 369 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12328 | 0.060 |
Why?
|
Epinephrine | 1 | 2008 | 795 | 0.060 |
Why?
|
Vitamin D | 1 | 2018 | 3197 | 0.060 |
Why?
|
Emotions | 1 | 2016 | 2642 | 0.060 |
Why?
|
Age Factors | 1 | 2021 | 18349 | 0.060 |
Why?
|
Psychometrics | 1 | 2012 | 2995 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2867 | 0.060 |
Why?
|
Language | 2 | 2022 | 1447 | 0.050 |
Why?
|
Pediatrics | 1 | 2018 | 3454 | 0.050 |
Why?
|
Dietary Carbohydrates | 2 | 2023 | 904 | 0.050 |
Why?
|
RNA, Viral | 2 | 2021 | 2907 | 0.050 |
Why?
|
Air Pollutants | 1 | 2016 | 2801 | 0.050 |
Why?
|
Insulin Resistance | 1 | 2016 | 3858 | 0.050 |
Why?
|
Hemoglobins | 1 | 2008 | 1529 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2016 | 4220 | 0.050 |
Why?
|
Immunoglobulin Isotypes | 1 | 2021 | 158 | 0.050 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2019 | 482 | 0.050 |
Why?
|
Respiration | 1 | 2008 | 1650 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7274 | 0.050 |
Why?
|
Health Surveys | 1 | 2011 | 4022 | 0.050 |
Why?
|
Telemedicine | 1 | 2017 | 2844 | 0.050 |
Why?
|
Incidence | 2 | 2015 | 20913 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14740 | 0.050 |
Why?
|
Mental Health | 1 | 2014 | 2946 | 0.040 |
Why?
|
Neuropsychological Tests | 1 | 2012 | 6963 | 0.040 |
Why?
|
Health Care Surveys | 2 | 2020 | 2448 | 0.040 |
Why?
|
Terbutaline | 1 | 1999 | 24 | 0.040 |
Why?
|
Iron | 1 | 2008 | 1776 | 0.040 |
Why?
|
Sulindac | 1 | 1999 | 29 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2021 | 625 | 0.040 |
Why?
|
Tocolytic Agents | 1 | 1999 | 25 | 0.040 |
Why?
|
Attitude of Health Personnel | 3 | 2020 | 3844 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2022 | 780 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13237 | 0.040 |
Why?
|
Chylothorax | 1 | 2019 | 84 | 0.040 |
Why?
|
Muscle Relaxation | 1 | 1998 | 142 | 0.040 |
Why?
|
Risk | 1 | 2010 | 9684 | 0.040 |
Why?
|
Omentum | 1 | 1998 | 170 | 0.040 |
Why?
|
Texas | 1 | 2018 | 394 | 0.040 |
Why?
|
Obstetric Labor, Premature | 1 | 1999 | 282 | 0.040 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 1999 | 370 | 0.040 |
Why?
|
Antibody Formation | 1 | 2021 | 1398 | 0.040 |
Why?
|
Telomere | 1 | 2022 | 907 | 0.030 |
Why?
|
Benchmarking | 1 | 2023 | 1034 | 0.030 |
Why?
|
Blood Glucose | 1 | 2010 | 6237 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2023 | 1671 | 0.030 |
Why?
|
Prognosis | 1 | 2015 | 28901 | 0.030 |
Why?
|
Iodides | 1 | 2014 | 41 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 1584 | 0.030 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 1995 | 337 | 0.030 |
Why?
|
Primary Health Care | 1 | 2011 | 4537 | 0.030 |
Why?
|
Leukocytes | 1 | 2022 | 2035 | 0.030 |
Why?
|
Canada | 1 | 2019 | 2021 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2016 | 62693 | 0.030 |
Why?
|
Term Birth | 1 | 2014 | 136 | 0.030 |
Why?
|
Arteries | 2 | 1998 | 1116 | 0.030 |
Why?
|
Pulmonary Wedge Pressure | 1 | 1994 | 264 | 0.030 |
Why?
|
Chorioamnionitis | 1 | 2014 | 156 | 0.030 |
Why?
|
Labor, Induced | 1 | 2014 | 146 | 0.030 |
Why?
|
Education, Medical, Continuing | 1 | 2018 | 840 | 0.030 |
Why?
|
Fetal Weight | 1 | 2012 | 80 | 0.030 |
Why?
|
Sodium Chloride, Dietary | 1 | 2014 | 281 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1998 | 1504 | 0.030 |
Why?
|
Breast | 1 | 2021 | 1950 | 0.030 |
Why?
|
Cardiac Output | 1 | 1994 | 857 | 0.030 |
Why?
|
Vehicle Emissions | 1 | 2016 | 665 | 0.020 |
Why?
|
Spirometry | 1 | 2014 | 863 | 0.020 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 1995 | 509 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2022 | 2674 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 1994 | 1528 | 0.020 |
Why?
|
Patient Admission | 1 | 2018 | 1383 | 0.020 |
Why?
|
Glucose Solution, Hypertonic | 1 | 2009 | 10 | 0.020 |
Why?
|
Lung | 1 | 2008 | 9782 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2018 | 1744 | 0.020 |
Why?
|
Biometry | 1 | 2012 | 558 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2030 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 1994 | 1871 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1776 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2010 | 1149 | 0.020 |
Why?
|
Medicaid | 1 | 2020 | 2711 | 0.020 |
Why?
|
Animals | 3 | 2020 | 168368 | 0.020 |
Why?
|
Glucose Intolerance | 1 | 2010 | 575 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 1998 | 4454 | 0.020 |
Why?
|
Triglycerides | 1 | 2013 | 2447 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2018 | 3514 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2008 | 1099 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19811 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2010 | 2974 | 0.020 |
Why?
|
Dietary Proteins | 1 | 2009 | 959 | 0.010 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2013 | 1338 | 0.010 |
Why?
|
Double-Blind Method | 2 | 2013 | 11985 | 0.010 |
Why?
|
Probability | 1 | 2009 | 2500 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 1995 | 2365 | 0.010 |
Why?
|
Health Behavior | 1 | 2014 | 2624 | 0.010 |
Why?
|
Dietary Fats | 1 | 2009 | 2013 | 0.010 |
Why?
|
Ultrasonography | 1 | 1994 | 5941 | 0.010 |
Why?
|
Ductus Arteriosus | 1 | 1999 | 39 | 0.010 |
Why?
|
Gravidity | 1 | 1998 | 51 | 0.010 |
Why?
|
Bradykinin | 1 | 1998 | 214 | 0.010 |
Why?
|
Odds Ratio | 1 | 2010 | 9846 | 0.010 |
Why?
|
Pulsatile Flow | 1 | 1999 | 332 | 0.010 |
Why?
|
Oxyhemoglobins | 1 | 1998 | 216 | 0.010 |
Why?
|
Urine | 1 | 1999 | 370 | 0.010 |
Why?
|
Endothelin-1 | 1 | 1998 | 313 | 0.010 |
Why?
|
Amniotic Fluid | 1 | 1999 | 366 | 0.010 |
Why?
|
Cerebral Arteries | 1 | 1999 | 492 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 1998 | 916 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5702 | 0.010 |
Why?
|
Models, Statistical | 1 | 2009 | 5113 | 0.010 |
Why?
|
Remission Induction | 1 | 1995 | 2378 | 0.010 |
Why?
|
Nitric Oxide | 1 | 1998 | 2121 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2014 | 15070 | 0.000 |
Why?
|
Enzyme Inhibitors | 1 | 1998 | 3802 | 0.000 |
Why?
|